Worldwide, 2.5 million people live with the diagnosis of multiple sclerosis.
We want to help make better and safer therapy options available more quickly to patients.
The SLCMSR pursues an approach which is unique in medical research worldwide: the institute is bundling and networking innovative statistical methods, the latest information technology and leading expert medical knowledge from the field of MS.
The goals of this international project are to accelerate the process of research on the causes of MS and to develop new and more effective medication and therapies. The basis for these efforts is the world's most powerful MS database.